Regeneron Pharmaceuticals (NASDAQ:REGN) Lowered to “Sector Perform” Rating by Royal Bank of Canada
Royal Bank of Canada lowered shares of Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) from an outperform rating to a sector perform rating in a research report released on Friday,Briefing.com Automated Import reports. They currently have $662.00 price target on the biopharmaceutical company’s stock. Other research analysts also recently issued reports about the company. Canaccord Genuity […]
Royal Bank of Canada lowered shares of Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) from an outperform rating to a sector perform rating in a research report released on Friday,Briefing.com Automated Import reports. They currently have $662.00 price target on the biopharmaceutical company’s stock. Other research analysts also recently issued reports about the company. Canaccord Genuity […]
